Listed pharmaceutical companies suffering from depressed work efficiency

Published: 2016-11-22 11:03:34

Updated: 2016-11-22 11:03:34

As getting weakened in marketability, listed pharmaceutical companies are criticized to have lowered work efficiency as well.

According to the Yakup Shinmoon’s analysis result of KOSDAQ and KOSPI listed pharmaceutical companies’ 2016 3^rd quarter reports, their net profit/sales rate by this September was aggregated at 6.0%.

The rate is a ratio representing relationship between net profits and ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.